Latest Pharmaceuticals policy Stories
Since 2000, more than $600 billion invested in developing new medicines for patients WASHINGTON, April 20, 2015 /PRNewswire-USNewswire/ -- Pharmaceutical Research and Manufacturers
So Called "Consumer Protections" Increase Costs: NCPA DALLAS, April 20, 2015 /PRNewswire-USNewswire/ -- Increasing unnecessary regulations on drug plans could inflict higher costs on the 220
DENVER, April 20, 2015 /PRNewswire/ -- Med-X, Inc. announced today the appointments of Allan L. Kurtz D.O. and Morton I. Hyson M.D. to its Board of Directors. "Dr.
POTTERS BAR, England and PITTSBURGH, April 17, 2015 /PRNewswire/ -- Mylan N.V.
Regulatory Compliance Associates® Inc.
Webinar will address some of Inflexxion’s recent findings that highlight the relationship between prescription opioid abuse and prescription opioid availability. Newton,
Biosimilars Council Releases First Biosimilars Handbook for U.S.
BSCG is the first to offer protection against drugs not banned in sport LOS ANGELES, April 16, 2015 /PRNewswire/ -- In broadening its services to include a range of new protections
Service Simplifies Prescription Medication Management through Delivering, Sorting, and Refilling Medication Manchester, N.H., April 15, 2015 /PRNewswire/ -- PillPack, the pharmacy that simplifies
CORAL SPRINGS, Florida, April 15, 2015 /PRNewswire/ -- For consumers wanting to use supplements to improve their nutrition and sport performance through pharmaceutical